Patents by Inventor Ippei Kurimoto

Ippei Kurimoto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7815939
    Abstract: Regarding an object of sufficient suppression of unpleasant taste in the oral cavity and quick dissolution in the gastrointestinal tract, which is generated when a drug having a strong unpleasant taste such as bitterness, astringency and the like is applied to a quickly disintegrating preparations in the oral cavity, this invention has achieved the aforementioned object for the first time by employing a constitution of coating a coat of a water-soluble polymer and a specified ratio of a pH-independent water-insoluble polymer and hydroxypropylcellulose.
    Type: Grant
    Filed: July 19, 2006
    Date of Patent: October 19, 2010
    Assignee: Astellas Pharma Inc.
    Inventors: Yuki Kasashima, Ippei Kurimoto, Hitoshi Kawai
  • Publication number: 20100062063
    Abstract: Provided is a preparation of ramosetron which is stable under irradiation with light. The solid pharmaceutical composition of the present invention can provide a stable preparation by blending a compound absorbing light having a specific wavelength with ramosetron which is unstable, usually under irradiation with light, or a pharmaceutically acceptable salt thereof. Particularly, this technique is useful because it is adaptable to a preparation containing ramosetron or a pharmaceutically acceptable salt thereof at a low content or an orally disintegrating tablet containing ramosetron or a pharmaceutically acceptable salt thereof. Also, the present invention relates to a method for stabilizing a solid pharmaceutical composition of ramosetron or a pharmaceutically acceptable salt thereof, which is characterized by blending a compound having characteristics of absorbing light having a specific wavelength.
    Type: Application
    Filed: September 12, 2007
    Publication date: March 11, 2010
    Applicant: ASTELLAS PHARMA INC.
    Inventors: Hiroyuki Umejima, Ippei Kurimoto, Atsushi Kanbayashi, Chieko Mori
  • Publication number: 20080221047
    Abstract: A pharmaceutical composition comprising aminoalkyl methacrylate copolymer E, an acidic substance, and a poorly-soluble drug, wherein the aminoalkyl methacrylate copolymer E and the acidic substance are uniformly mixed, and solubility of the poorly-soluble drug is maintained for at least 30 minutes is disclosed.
    Type: Application
    Filed: December 26, 2007
    Publication date: September 11, 2008
    Inventors: Takatsune Yoshida, Keiichi Yoshihara, Hiroyuki Umejima, Ippei Kurimoto
  • Publication number: 20070231399
    Abstract: Regarding an object of sufficient suppression of unpleasant taste in the oral cavity and quick dissolution in the gastrointestinal tract, which is generated when a drug having a strong unpleasant taste such as bitterness, astringency and the like is applied to a quickly disintegrating preparations in the oral cavity, this invention has achieved the aforementioned object for the first time by employing a constitution of coating a coat of a water-soluble polymer and a specified ratio of a pH-independent water-insoluble polymer and hydroxypropylcellulose.
    Type: Application
    Filed: July 19, 2006
    Publication date: October 4, 2007
    Applicant: Astellas Pharma, Inc.
    Inventors: Yuki Kasashima, Ippei Kurimoto, Hitoshi Kawai
  • Publication number: 20050175689
    Abstract: The present invention makes it possible to provide drug-containing coated microparticles for quick-disintegrating oral tablets wherein microparticles containing a drug with an unpleasant taste are coated with a film composed of (1) a pH-independent water-insoluble polymer accounting for 60% or more but less than 80% of the film and (2) a pH-independent water-soluble substance accounting for more than 20% to 40% or less of the film, these microparticles being characterized in that the rate of dissolution of the drug from the drug-containing microparticles is 0% to 10% in one minute and 80% to 100% in 30 minutes, and the average particle diameter is 350 ?m or less, in order to realize sufficient control of oral drug dissolution and fast gastrointestinal drug dissolution.
    Type: Application
    Filed: October 27, 2004
    Publication date: August 11, 2005
    Applicant: Yamanouchi Pharmaceutical Co., Ltd.
    Inventors: Ippei Kurimoto, Yuki Kasashima, Hitoshi Kawai, Yuuki Takaishi, Masataka Katsuma, Hiroshi Ohi, Takayuki Yoshida, Hiroaki Tasaki